A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Verastem, Inc.
Pfizer
Inhibrx Biosciences, Inc
Masonic Cancer Center, University of Minnesota
University of Arizona